290 related articles for article (PubMed ID: 3054641)
1. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
2. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
4. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
5. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Campylobacter pylori does not alter gastric acid secretion.
Montbriand JR; Appelman HD; Cotner EK; Nostrant TT; Elta GH
Am J Gastroenterol; 1989 Dec; 84(12):1513-6. PubMed ID: 2596452
[TBL] [Abstract][Full Text] [Related]
7. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
[TBL] [Abstract][Full Text] [Related]
8. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
Lanza FL; Skoglund ML; Rack MF; Yardley JH
Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Elta GH; Murphy R; Behler EM; Barnett JL; Nostrant TT; Kern S; Appelman H
Am J Gastroenterol; 1989 Jun; 84(6):643-6. PubMed ID: 2729235
[TBL] [Abstract][Full Text] [Related]
10. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
[TBL] [Abstract][Full Text] [Related]
11. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
[TBL] [Abstract][Full Text] [Related]
13. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and therapy of Campylobacter pylori infection].
Wagner S; Freise J; Bär W; Fritsch S; Schmidt FW
Dtsch Med Wochenschr; 1989 Mar; 114(11):407-13. PubMed ID: 2707124
[TBL] [Abstract][Full Text] [Related]
15. Gastric antral erosions and Helicobacter pylori infection in cirrhotic patients: a pilot controlled study of oral bismuth vs ranitidine therapy.
Balzano A; Mosca S; Amitrano L; Di Blasi A; Piccirillo MM; Gigliotti T
Ital J Gastroenterol; 1991; 23(3):132-5. PubMed ID: 1742507
[TBL] [Abstract][Full Text] [Related]
16. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
Iserhard R; Freise J; Wagner S; Bokemeyer B; Weissbrodt H; Fritsch RS; Soudah B; Schmidt FW
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():38-44. PubMed ID: 1982107
[TBL] [Abstract][Full Text] [Related]
19. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Iser JH; Buttigieg RJ; Iseli A
Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
[TBL] [Abstract][Full Text] [Related]
20. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
Lazzaroni M; Petrillo M; Bianchi Porro G
Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
